SG Americas Securities’s Bristol-Myers Squibb BMY Stock Holding History

SG Americas Securities’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-901,600	Closed	-$2.41M	–	3249
2025 Q4	$2.41M	Buy	+901,600	New	+$43.4M	﹤0.01%	1414
2025 Q2	–	Sell	-18,300	Closed	-$106K	–	2972
2025 Q1	$106K	Sell	18,300 -11,000	-38%	-$641K	﹤0.01%	3003
2024 Q4	$83K	Sell	29,300 -300,000	-91%	-$16.8M	﹤0.01%	2791
2024 Q3	$298K	Buy	329,300 +300,200	+1,032%	+$14.1M	﹤0.01%	2149
2024 Q2	$15K	Sell	29,100 -45,000	-61%	-$2.01M	﹤0.01%	2769
2024 Q1	$123K	Buy	74,100 +29,100	+65%	+$1.48M	﹤0.01%	2384
2023 Q4	$2K	Hold	45,000	–	–	﹤0.01%	3054
2023 Q3	$7K	Hold	45,000	–	–	﹤0.01%	3067
2023 Q2	$32K	Hold	45,000	–	–	﹤0.01%	2158
2023 Q1	$104K	Buy	+45,000	New	+$3.17M	﹤0.01%	2881
2022 Q2	–	Sell	-150,100	Closed	-$179K	–	3421
2022 Q1	$179K	Sell	150,100 -99,900	-40%	-$6.71M	﹤0.01%	2486
2021 Q4	$518K	Buy	250,000 +200,000	+400%	+$11.7M	﹤0.01%	2157
2021 Q3	$20K	Hold	50,000	–	–	﹤0.01%	3780
2021 Q2	$112K	Hold	50,000	–	–	﹤0.01%	2598
2021 Q1	$122K	Sell	50,000 -330,000	-87%	-$20.5M	﹤0.01%	2975
2020 Q4	$538K	Sell	380,000 -55,000	-13%	-$3.38M	﹤0.01%	1934
2020 Q3	$828K	Sell	435,000 -154,500	-26%	-$9.3M	0.01%	1302
2020 Q2	$1.2M	Buy	589,500 +109,500	+23%	+$6.55M	0.01%	1236
2020 Q1	$2.24M	Sell	480,000 -1,331,600	-74%	-$81.4M	0.02%	739
2019 Q4	$13.3M	Buy	1,811,600 +890,100	+97%	+$51M	0.12%	134
2019 Q3	$3.3M	Buy	921,500 +785,400	+577%	+$36.9M	0.03%	643
2019 Q2	$139K	Sell	136,100 -187,200	-58%	-$8.72M	﹤0.01%	2620
2019 Q1	$47K	Sell	323,300 -25,100	-7%	-$1.25M	﹤0.01%	3207
2018 Q4	$146K	Buy	348,400 +52,000	+18%	+$2.79M	﹤0.01%	2530
2018 Q3	$871K	Buy	296,400 +235,600	+388%	+$14M	0.01%	1792
2018 Q2	$79K	Sell	60,800 -44,800	-42%	-$2.42M	﹤0.01%	3110
2018 Q1	$282K	Sell	105,600 -6,500	-6%	-$418K	﹤0.01%	2219
2017 Q4	$195K	Buy	112,100 +22,400	+25%	+$1.4M	﹤0.01%	2452
2017 Q3	$255K	Sell	89,700 -149,900	-63%	-$8.75M	﹤0.01%	2383
2017 Q2	$99K	Sell	239,600 -945,400	-80%	-$51.4M	﹤0.01%	2931
2017 Q1	$139K	Sell	1,185,000 -26,500	-2%	-$1.45M	﹤0.01%	2721
2016 Q4	$378K	Buy	1,211,500 +928,200	+328%	+$50.7M	﹤0.01%	1889
2016 Q3	$33K	Buy	283,300 +40,300	+17%	+$2.59M	﹤0.01%	3214
2016 Q2	$560K	Hold	243,000	–	–	﹤0.01%	1636
2016 Q1	$219K	Sell	243,000 -86,800	-26%	-$5.47M	﹤0.01%	2148
2015 Q4	$508K	Buy	+329,800	New	+$21.8M	﹤0.01%	1585
2015 Q3	–	Sell	-459,200	Closed	-$1.91M	–	2125
2015 Q2	$1.91M	Buy	459,200 +270,900	+144%	+$17.9M	0.01%	740
2015 Q1	$1.25M	Buy	188,300 +30,000	+19%	+$1.88M	0.01%	1022
2014 Q4	$741K	Sell	158,300 -109,700	-41%	-$6.19M	﹤0.01%	1387
2014 Q3	$1.13M	Sell	268,000 -19,300	-7%	-$964K	0.01%	1111
2014 Q2	$866K	Buy	287,300 +134,200	+88%	+$6.61M	0.01%	1431
2014 Q1	$1.14M	Sell	153,100 -681,200	-82%	-$36.2M	﹤0.01%	1082
2013 Q4	$16.6M	Sell	834,300 -160,200	-16%	-$8.16M	0.07%	283
2013 Q3	$14M	Sell	994,500 -34,400	-3%	-$1.51M	0.06%	312
2013 Q2	$12.2M	Buy	+1,028,900	New	+$44.7M	0.06%	322

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SG Americas Securities's BMY Position: Q1 2026 in Review

SG Americas Securities increased its Bristol-Myers Squibb (BMY) stake by 240% in Q1 2026, buying an estimated $366M and bringing the position to 8,910,032 shares worth $540M. The position accounts for 0.58% of the portfolio, ranked #23.

SG Americas Securities first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

SG Americas Securities held 8,910,032 shares of Bristol-Myers Squibb worth $540M as of Q1 2026.
SG Americas Securities bought 6,286,007 Bristol-Myers Squibb shares in Q1 2026, an estimated $366M.
Bristol-Myers Squibb made up 0.58% of SG Americas Securities's portfolio in Q1 2026, its #23 holding.
SG Americas Securities first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.